STAT

Near the campus cow pasture, a scientist works to grow human organs — in pigs

Without Dr. Pablo Juan Ross, an animal scientist, the groundbreaking creation of a part-human, part-animal chimera might not have been possible.

DAVIS, Calif. — Like many of the scientists who helped usher in the groundbreaking creation of a part-human, part-animal chimera earlier this year, biologist Dr. Pablo Juan Ross is no stranger to cutting-edge tools such as CRISPR and stem cells. But he also knows his way around the inside of a pig uterus.

While growing human cells inside fetal pigs involved some of science’s fanciest new tricks, it also required something decidedly more mundane: a farm, stocked with livestock and staffed with people like Ross who know how to handle them.

Trained as a veterinarian and animal scientist, Ross works at the University of California, Davis, where hay is piled two-stories high on Dairy Road, signs read “Meat sales today,” cows graze next to soccer fields, and the swine facility, filled with squealing black and white Hampshire piglets, has its own Facebook page.

Without Ross and his deep understanding of the peculiarities of various livestock species and their embryos, the daunting chimera experiments might not have been possible.

“He was indispensable,” said Jun Wu, a human stem cell expert at the Salk Institute who found himself in the unlikely position of helping hoist a 200-pound sow onto an operating table during one of his visits here to work with Ross.

Read more: The creator of the pig-human chimera keeps proving other scientists wrong

The experiments, led by Wu and his Salk colleague and published in January, were hailed as a tremendous accomplishment. The first-ever creation of organisms

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly’s Zepbound For Sleep Apnea, The FDA Budget, And More
Eli Lilly reported positive results for Zepbound in obstructive sleep apnea, giving the medication a new edge in the highly competitive obesity market.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.

Related Books & Audiobooks